Figure 5. Effect of methylophiopogonanone A (MO-A) on hepatic A, lipoprotein lipase (LPL) and C, hepatic lipase (HL) activities and serum B, LPL and D, HL activities in hyperlipidemia rats. Data are reported as means±SD, n=8 rats in each group. #P<0.05, compared with normal control (NC) group; *P<0.05, **P<0.01, compared with high-fat diet (HFD) group (ANOVA).
